Sylvia Lee, M.D.

Sylvia Lee M.D.
faculty member

Sylvia Lee, M.D.

Assistant Member, Program in Immunology
Clinical Research Division, Fred Hutch

Fax: 206.606.1435
Mailstop: K2-231

Dr. Sylvia Lee studies a form of cancer immunotherapy called tumor infiltrating lymphocyte, or TIL, therapy. This experimental strategy uses a mix of a patient’s own immune cells to attack their tumors. It may hold particular promise for treating patients with highly mutated cancers like melanoma. Dr. Lee leads Fred Hutch’s TIL program — one of only four in the U.S. — which offers clinical trials of this approach to patients. She leads TIL clinical trials and develops new forms of TIL therapy in the laboratory. An oncologist, Dr. Lee also treats patients with melanoma and lung cancers at Seattle Cancer Care Alliance, Fred Hutch’s clinical-care partner.

Other Appointments & Affiliations

Assistant Professor
University of Washington School of Medicine

Education

M.D., University of North Carolina School of Medicine

Internship, University of Washington School of Medicine, Division of General Internal Medicine

Residency, University of Washington School of Medicine, Division of General Internal Medicine

Fellowship, University of Washington School of Medicine, Division of Oncology and Fred Hutchinson Cancer Research Center

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210